Suvoda

Executive Summary

Suvoda is a global clinical trial technology company headquartered in Barcelona, Spain, founded in 2013. The company offers a real-time, modular software platform that streamlines complex clinical trial workflows. Its key solutions include Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, and integrated patient payment and travel scheduling through Greenphire. By providing a unified platform for sponsors, CROs, sites, and patients, Suvoda enables data-driven decision-making during critical trial moments, enhancing efficiency and reducing timelines. The clinical trial software market is rapidly expanding, driven by increasing trial complexity and demand for decentralized solutions. Suvoda's comprehensive suite addresses key pain points in patient engagement, data integrity, and operational efficiency. With a strong focus on usability and real-time data, the company is well-positioned to capture market share. As the industry continues to digitize, Suvoda's platform offers a compelling value proposition. Potential catalysts include securing a major partnership with a top-10 pharma, launching an AI-powered analytics module, and closing a Series B funding round to accelerate growth.

Upcoming Catalysts (preview)

• Q3 2026Major pharma partnership for IRT/eCOA deployment60% success
• Q4 2026Launch of AI-driven predictive analytics module50% success
• Q2 2026Series B funding round to expand global sales70% success